Target & Activity
| Target | Activity | Value |
|---|---|---|
| HSP90 | EC50 | 62 nM |
| GRP94 | EC50 | 65 nM |
Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A2058 | IC50 | 2.1 nM | Cytotoxicity against human A2058 cells by MTT assay | [PMID: 18929486] |
| A549 | IC50 | 68 nM | Cytotoxicity against human A549 cells after 72 hrs by celltiter-glo assay | [PMID: 19405528] |
| AGS | IC50 | 0.0036 μM | Inhibition of hypoxia-induced HIF1 activation in human AGS cells by reporter gene assay | [PMID: 18359631] |
| AGS | IC50 | 0.036 μM | Inhibition of HIF1 activation in human AGS cells assessed as inhibition of hypoxia-induced luciferase expression after 16 hrs by reporter assay | [PMID: 17583950] |
| AGS | IC50 | 16 μM | Viability of human AGS cells under normoxic conditions after 24 hrs by MTT assay | [PMID: 17583950] |
| AGS | IC50 | 16 μM | Cytotoxicity against human AGS cells by MTT assay | [PMID: 18359631] |
| BT-549 | IC50 | 17.1 μM | Anticancer activity against human BT-549 cells assessed as cell growth inhibition incubated for 72 hrs by CCK-8 assay | [PMID: 33650861] |
| CCRF-CEM | IC50 | 2500 nM | Cytotoxicity against human paclitaxel-resistant CCRF-CEM cells after 72 hrs by celltiter-96 aqueous one solution assay | [PMID: 19405528] |
| CCRF-CEM | IC50 | 540 nM | Cytotoxicity against human CCRF-CEM cells after 72 hrs by celltiter-96 aqueous one solution assay | [PMID: 19405528] |
| HCT-116 | IC50 | 0.05 μM | Cytotoxicity against human HCT116 cells by Alamar blue assay | [PMID: 20662534] |
| HCT-116 | IC50 | 0.78 μM | Antiproliferative activity against human HCT116 cells assessed as inhibition of cell viability after 48 hrs by MTT assay | [PMID: 24582477] |
| HCT-116 | IC50 | 1.21 μM | Antiproliferative activity against human HCT116 cells after 48 hrs by MTT assay | [PMID: 24763261] |
| HCT-116 | IC50 | 57 nM | Cytotoxicity against human HCT116 cells after 72 hrs | [PMID: 19231864] |
| HeLa | IC50 | 2.06 μM | Cytotoxicity against human HeLa cells by MTT assay | [PMID: 18359631] |
| Hep 3B2 | IC50 | > 30 μM | Inhibition of hypoxia-induced HIF1 activation in human Hep3B cells by pGL3-HRE-luciferase reporter gene assay | [PMID: 19072214] |
| Hep 3B2 | IC50 | > 50 μM | Viability of human Hep3B cells under normoxic conditions after 24 hrs by MTT assay | [PMID: 17583950] |
| Hep 3B2 | IC50 | 0.057 μM | Inhibition of hypoxia-induced HIF1alpha protein accumulation in human Hep3B cells treated for 30 mins measured after 12 hrs by Western blot analysis | [PMID: 20469887] |
| Hep 3B2 | IC50 | 0.061 μM | Inhibition of HIF1 activation in human Hep3B cells assessed as inhibition of hypoxia-induced luciferase expression after 16 hrs by reporter assay | [PMID: 17583950] |
| Hep 3B2 | IC50 | 0.079 μM | Inhibition of hypoxia-induced VEGF protein secretion in human Hep3B cells after 16 hrs by ELISA | [PMID: 20469887] |
| Hep 3B2 | IC50 | 57.2 nM | Inhibition of hypoxia-induced HIF1alpha protein accumulation in human Hep3B cells treated for 30 mins measured after 12 hrs by Western blot analysis | [PMID: 19072214] |
20 records · Scroll to view more